MototsuguTanaka NiigataJapan

• Clinical Impacts and Importance of Minimizing Drug Approval Delay
  NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan
• HCE (hierarchical composite end points) and eGFR slope, as potential solutions to delays in approval
  HiddoLambers Heerspink Speaker h.j.lambers.heerspink@umcg.nlNetherlands
• Bridging Academia and Regulators in Kidney Drug Development: Insights from Japan
  MototsuguTanaka Speaker Japan
• Panel Discussion
  DustinLittle Moderator United States

  HiddoLambers Heerspink Speaker h.j.lambers.heerspink@umcg.nlNetherlands

  MototsuguTanaka Speaker Japan

  NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan